| PERIOD ENDING | 23-May-09 | 31-Jan-09 | 8-Nov-08 | 16-Aug-08 | | Total Revenue | 22,799,000 | 17,260,000 | 17,580,000 | 18,053,000 | | Cost of Revenue | 17,267,000 | 13,088,000 | 13,552,000 | 14,072,000 | | | Gross Profit | 5,532,000 | 4,172,000 | 4,028,000 | 3,981,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,235,000 | 3,165,000 | 3,214,000 | 3,106,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 453,000 | 348,000 | 335,000 | 327,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 844,000 | 659,000 | 479,000 | 548,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 844,000 | 659,000 | 479,000 | 548,000 | | Interest Expense | 163,000 | 115,000 | 106,000 | 112,000 | | Income Before Tax | 681,000 | 544,000 | 373,000 | 436,000 | | Income Tax Expense | 250,000 | 195,000 | 136,000 | 159,000 | | Minority Interest | 4,000 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 435,000 | 349,000 | 237,000 | 277,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 435,000 | 349,000 | 237,000 | 277,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $435,000 | $349,000 | $237,000 | $277,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
